awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36088616-1486C827-F556-407E-ACB9-6FDC0CE41D37
Q36088616-1486C827-F556-407E-ACB9-6FDC0CE41D37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36088616-1486C827-F556-407E-ACB9-6FDC0CE41D37
Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
P2860
Q36088616-1486C827-F556-407E-ACB9-6FDC0CE41D37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36088616-1486C827-F556-407E-ACB9-6FDC0CE41D37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a8a2f3ef24ca84d1ef8642714975e0c045237d9
P2860
Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.